
201 - 500 employés
Fondée en 1997
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
💰 €525 300 Post-IPO Equity en 2012-04
Healthcare • Biotechnology • Pharmaceuticals
Corcept Therapeutics est une entreprise biopharmaceutique axée sur le potentiel de la modulation du cortisol pour révolutionner le traitement des maladies graves. L'entreprise se consacre à la compréhension et à la modulation de l'activité du cortisol au niveau du récepteur des glucocorticoïdes afin de développer de nouveaux traitements pour des troubles sévères. Avec plus de 30 études en cours, Corcept construit une base scientifique pour proposer de nouvelles approches dans des domaines tels que l'endocrinologie, l'oncologie, le métabolisme et la neurologie. L'objectif de l'entreprise est de proposer des thérapies innovantes aux patients en explorant de nouvelles possibilités dans la science de la modulation du cortisol.
🕒 il y a 3 jours
🇺🇸 États-Unis – Télétravail
💵 $209 100 - $307 600 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
👻 Score fantôme 0%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Corcept Therapeutics, pas via un site d'emploi
Repérée par Remote Rocketship il y a 3 jours
Toujours ouverte sur le site de Corcept Therapeutics. Vérifiée il y a 1 heure.

201 - 500 employés
Fondée en 1997
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
💰 €525 300 Post-IPO Equity en 2012-04
Healthcare • Biotechnology • Pharmaceuticals
Corcept Therapeutics est une entreprise biopharmaceutique axée sur le potentiel de la modulation du cortisol pour révolutionner le traitement des maladies graves. L'entreprise se consacre à la compréhension et à la modulation de l'activité du cortisol au niveau du récepteur des glucocorticoïdes afin de développer de nouveaux traitements pour des troubles sévères. Avec plus de 30 études en cours, Corcept construit une base scientifique pour proposer de nouvelles approches dans des domaines tels que l'endocrinologie, l'oncologie, le métabolisme et la neurologie. L'objectif de l'entreprise est de proposer des thérapies innovantes aux patients en explorant de nouvelles possibilités dans la science de la modulation du cortisol.
• Serve as a senior clinical associate within Oncology, reporting to the President of Oncology • Lead high-level clinical and scientific engagement with external oncology experts and serve as a bridge between Clinical Development, Medical Affairs, Commercial, Market Access, HEOR, Pharmacovigilance, and Regulatory partners • Help shape and execute the introduction of Lifyorli in clinical practice, primarily in the U.S. market • Support execution of medical affairs strategy and serve as the primary contact for practitioners seeking peer-to-peer interactions • Support payer-facing engagement leveraging clinical guidelines • Support medical priorities related to product adoption and long-term integration into clinical practice • Provide clinical and medical/scientific expertise for medical affairs priorities, tactical planning, internal training, advisory boards, congress activities, and cross-functional initiatives • Identify unmet medical needs and translate scientific insights into practical clinical guidance • Lead peer-to-peer scientific interactions with oncology experts, KOLs, clinical researchers, academic centers, and external medical stakeholders • Engage physicians and oncology experts through advisory boards, congress interactions, speaker preparation, and insight-gathering activities • Represent Corcept at medical conferences and external events • Provide clinical input to post-approval evidence generation, including RWE, ISS, registries, and other data-generation activities • Review ISS proposals and collaborate on program design, prioritization, and governance • Evaluate clinical trial results, post-marketing evidence, medical literature, and emerging oncology trends • Support accurate, balanced, and compliant scientific, educational, medical information, and promotional review materials • Interpret and influence clinical guideline updates and treatment pathways, including NCCN and ASCO • Translate guideline and pathway changes into clinical and business implications for internal teams • Partner with Market Access and HEOR on payer value propositions, outcomes, comparative effectiveness, and economic value • Participate in payer-facing discussions requiring deep clinical expertise • Develop and communicate safety-related clinical guidance with Pharmacovigilance, Clinical Development, and Medical Affairs • Translate safety data into clinician-facing recommendations, monitoring strategies, risk mitigation approaches, and adverse event management algorithms • Contribute to supportive care guidance and safety-related external communications
• MD required • Oncology experience required; gynecologic oncology experience preferred • 3-5+ years of relevant oncology practice, including fellowship • Experience engaging oncology experts, interpreting clinical evidence, and translating complex data into clear scientific and clinical communications • Demonstrated ability to evaluate scientific data, clinical literature, evolving treatment pathways, and oncology practice trends and apply insights to medical, launch, market access, and evidence-generation activities • Understanding of the U.S. healthcare environment, health technology assessment (HTA) considerations, payer evidence needs, and the pharmaceutical/biotechnology industry • Strong oral, written, and presentation skills, with the ability to communicate complex clinical concepts clearly to internal and external audiences • Collaborative, cross-functional leadership style with sound judgment and scientific rigor • Ability to operate effectively in a launch-focused, evolving environment • Ability to travel 25-30% or as needed • Applicants must be currently authorized to work in the United States on a full-time basis
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 3 jours
Directing enterprise network performance and strategy for CareSource’s managed-care health plans. Improving affordability, access, quality, provider performance, and network competitiveness across markets.
🇺🇸 États-Unis – Télétravail
💵 $113 000 - $197 700 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Global onboarding director scaling mid-market customer implementations for Cloudbeds' hotel management platform. Leading teams, deployment standards, metrics, and cross-functional delivery worldwide.
🇺🇸 États-Unis – Télétravail
💵 $160 000 - $190 000 / an
💰 €150 000 000 Series D en 2021-11
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Aviation Director leading air cargo strategy, carrier relationships, compliance, and financial performance. Supporting ICAT’s global freight forwarding and 3PL logistics operations.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Client Director managing carrier relationships, account strategy, and performance reporting for Accuserve’s managed repair and restoration services. Driving client satisfaction, retention, sales growth, and operational alignment.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Director owning national payer and health system relationships for PAA, a post-acute care healthcare technology company. Driving contractual outcomes, renewals, ROI, and cross-functional delivery.
🇺🇸 États-Unis – Télétravail
💰 Venture Round - Post Acute Analytics en 2025-09
⏰ Temps Plein
🔴 Expert
👔 Directeur
🗣️🇺🇸🇬🇧 Anglais requis